Systemic Activation of Macrophages and Treatment of Cancer Metastases by Liposomes containing Hydrophilic or Lipophilic Muramyl Dipeptide
- 1 January 1983
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.Proceedings of the National Academy of Sciences, 1981
- In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomesCellular Immunology, 1981
- The pathogenesis of cancer metastasisNature, 1980
- The effects of experimental conditions on the expression of in vitro-mediated tumor cytotoxicity mediated by murine macrophagesCancer Immunology, Immunotherapy, 1979
- Implications of immunological heterogeneity of tumoursNature, 1979
- Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouseInternational Journal of Immunopharmacology, 1979
- The Biology of Cancer Invasion and MetastasisAdvances in Cancer Research, 1978
- Metastasis Results from Preexisting Variant Cells Within a Malignant TumorScience, 1977
- Concepts for systemic treatment of micrometastasesCancer, 1975
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974